CDKN2A and central nervous system cancer: CDKN2a/b has previously been shown to be hypermethylated and downregulated in models of H3 K27M glioma.43 We show that decitabine induces hypomethylation over the CDKN2a/b promoters, accompanied by significant over-expression (Supplementary Figure 3c and d).